Using the new animal model, we proposed that patient-derived PBMC might trigger encephalitis pathogenesis by causing Il-1β-dependent BBB dysfunction, and that the IL1 receptor antagonist Anakinra is a potential treatment for anti-NMDAR encephalitis. This evidence concerns the gene IL1B and encephalitis.